Met-enkephalin immunoreactivity in blood platelets

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Met-enkephalin is an endogenous opioid peptide.
• Platelets are known to store and release various bioactive substances.

Purpose of the Study:

• To investigate the presence and characteristics of met-enkephalin in platelets.
• To explore the release mechanism and in vivo regulation of platelet met-enkephalin.
• To compare platelet met-enkephalin levels in normotensive and spontaneously hypertensive rats.

Main Methods:

• Radioimmunoassay (RIA) for detecting met-enkephalin immunoreactive material (met-enkephalin IR).
• Chromatographic techniques (thin-layer, gel filtration, high-pressure liquid) for material characterization.
• In vitro studies using thrombin stimulation.
• In vivo studies involving adrenalectomy and hypophysectomy in rats.
• Comparison of platelet met-enkephalin IR in Wistar-Kyoto rats and spontaneously hypertensive rats (SHR).

Main Results:

• Picogram amounts of met-enkephalin IR were detected in human, rat, and rabbit platelets.
• Platelet met-enkephalin IR behaved identically to synthetic met-enkephalin and no precursors were detected.
• Thrombin released platelet met-enkephalin IR and 5-hydroxytryptamine (5-HT) together, indicating co-localization.
• Adrenalectomy and hypophysectomy did not affect platelet met-enkephalin IR in rats.
• Spontaneously hypertensive rats exhibited lower platelet met-enkephalin IR concentrations compared to normotensive controls.

Conclusions:

• Platelets contain authentic met-enkephalin, not its precursors.
• Met-enkephalin and 5-HT likely share storage sites within platelet organelles.
• Platelet met-enkephalin levels are not regulated by the adrenal or pituitary glands.
• Altered platelet met-enkephalin levels may be associated with hypertension.